Literature DB >> 9649183

CD4+ T cells from 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis rodents migrate to the recipient's colon upon transfer; down-regulation by CD8+ T cells.

M J Palmen1, O L Wijburg, I H Kunst, H Kroes, E P van Rees.   

Abstract

CD4+ T cells play an important role in the aetiology of inflammatory bowel disease (IBD), but it is not clear which factor(s) cause activation of these cells. The aim of this study was to examine the effects of adoptive transfer of splenic (CD4+) T cells from TNBS/ethanol-sensitized donor rats to naive recipients and the migration pattern of transferred T cells. For the transfer experiments, colitis was induced in rats by colonic administration of TNBS/ethanol. Seventeen days later, either total splenic T cells or CD4+, or CD8+ T cells were transferred to naive recipients. At days 1, 2 and 3 after transfer, the recipients were killed and the migration pattern of the transferred T cells was studied, as well as inflammatory cells in several organs, including the colon. To determine cytokine profiles of the T cells, colitis was induced in mice. Therefore, different combinations of 2,4-dinitrobenzene sulfonic acid (DNBS) in ethanol or saline, or ethanol alone were intrarectally administered. At day 9 after induction of colitis, mice were killed and cytokine profiles in the colon were studied by reverse transcriptase-polymerase chain reaction (RT-PCR) and immunohistochemistry. The results show that CD4+ T cells from donor rats with TNBS/ethanol-induced colitis migrate in particular to the colon upon transfer to naive recipients, and that this process is down-regulated by CD8+ T cells. This migration is probably caused by T cell recognition of the colonic bacterial flora and initiates an inflammatory reaction in the recipient's colon, characterized by an increase of the recipient's own T cells, macrophages, and neutrophils. In the mice experiments we showed that a second administration of DNBS/ethanol or ethanol alone, which presumably causes bacterial translocation, results in increased numbers of T cells into the colon, accompanied by an increase in Th1 cytokines. These data suggest that Th1 cells recognize the colonic bacterial flora.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9649183      PMCID: PMC1904969          DOI: 10.1046/j.1365-2249.1998.00564.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  51 in total

1.  CD4 antibody treatment in Crohn's disease.

Authors:  A Stronkhorst; G N Tytgat; S J van Deventer
Journal:  Scand J Gastroenterol Suppl       Date:  1992

2.  Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus.

Authors:  R J Cahill; C J Foltz; J G Fox; C A Dangler; F Powrie; D B Schauer
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

3.  Stereologic estimation of volume-weighted mean nuclear volume as a predictor of prognosis in "thin" malignant melanoma.

Authors:  M Binder; I Dolezal; K Wolff; H Pehamberger
Journal:  J Invest Dermatol       Date:  1992-08       Impact factor: 8.551

4.  Colonic bacteria and bacterial translocation in experimental colitis.

Authors:  K R Gardiner; P J Erwin; N H Anderson; J G Barr; M I Halliday; B J Rowlands
Journal:  Br J Surg       Date:  1993-04       Impact factor: 6.939

5.  Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene.

Authors:  B Sadlack; H Merz; H Schorle; A Schimpl; A C Feller; I Horak
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

6.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

7.  Intestinal permeability and the prediction of relapse in Crohn's disease.

Authors:  J Wyatt; H Vogelsang; W Hübl; T Waldhöer; H Lochs
Journal:  Lancet       Date:  1993-06-05       Impact factor: 79.321

8.  Role of intestinal microflora in chronic inflammation and ulceration of the rat colon.

Authors:  S Videla; J Vilaseca; F Guarner; A Salas; F Treserra; E Crespo; M Antolín; J R Malagelada
Journal:  Gut       Date:  1994-08       Impact factor: 23.059

9.  Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice.

Authors:  F Powrie; M W Leach; S Mauze; L B Caddle; R L Coffman
Journal:  Int Immunol       Date:  1993-11       Impact factor: 4.823

10.  The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats.

Authors:  J D Taurog; J A Richardson; J T Croft; W A Simmons; M Zhou; J L Fernández-Sueiro; E Balish; R E Hammer
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

View more
  3 in total

1.  Glucocorticoid-induced tumour necrosis factor receptor family-related receptor signalling exacerbates hapten-induced colitis by CD4+ T cells.

Authors:  Sun K Lee; Beom K Choi; Young H Kim; Woo J Kang; Kwang H Kim; Shimon Sakaguchi; Jae H Suh; Tae Y Kim; Byoung S Kwon
Journal:  Immunology       Date:  2006-12       Impact factor: 7.397

2.  Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines.

Authors:  L A Dieleman; M J Palmen; H Akol; E Bloemena; A S Peña; S G Meuwissen; E P Van Rees
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

3.  Specific CTL activity of CD8+ TCR Vbeta14+ T cell in mouse 2, 4, 6-trinitrobenzene sulfonic acid-induced colitis.

Authors:  Toyoo Nitta; Hisashi Iwata; Yoshio Mori; Hisato Takagi; Toshio Hirota; Kazuto Kanetake; Yutaka Iida; Ken-Ichi Sakamoto; Takuya Yamada; Masanao Saio; Hajime Hirose
Journal:  Dig Dis Sci       Date:  2003-10       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.